US Patent

US10406108 — Thyroid hormone oral dosage forms and methods of using the same

Formulation · Assigned to Genus Lifesciences Inc · Expires 2038-03-23 · 12y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects novel thyroid hormone oral dosage forms and methods of making and using them.

USPTO Abstract

Novel thyroid hormone oral dosage forms and methods of making and using the thyroid hormone oral dosage forms are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
US10406108
Jurisdiction
US
Classification
Formulation
Expires
2038-03-23
Drug substance claim
No
Drug product claim
Yes
Assignee
Genus Lifesciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.